Nesprin proteins: bridging nuclear envelope dynamics to muscular dysfunction

Cell Commun Signal. 2024 Apr 2;22(1):208. doi: 10.1186/s12964-024-01593-y.

Abstract

This review presents a comprehensive exploration of the pivotal role played by the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex, with a particular focus on Nesprin proteins, in cellular mechanics and the pathogenesis of muscular diseases. Distinguishing itself from prior works, the analysis delves deeply into the intricate interplay of the LINC complex, emphasizing its indispensable contribution to maintaining cellular structural integrity, especially in mechanically sensitive tissues such as cardiac and striated muscles. Additionally, the significant association between mutations in Nesprin proteins and the onset of Dilated Cardiomyopathy (DCM) and Emery-Dreifuss Muscular Dystrophy (EDMD) is highlighted, underscoring their pivotal role in disease pathogenesis. Through a comprehensive examination of DCM and EDMD cases, the review elucidates the disruptions in the LINC complex, nuclear morphology alterations, and muscular developmental disorders, thus emphasizing the essential function of an intact LINC complex in preserving muscle physiological functions. Moreover, the review provides novel insights into the implications of Nesprin mutations for cellular dynamics in the pathogenesis of muscular diseases, particularly in maintaining cardiac structural and functional integrity. Furthermore, advanced therapeutic strategies, including rectifying Nesprin gene mutations, controlling Nesprin protein expression, enhancing LINC complex functionality, and augmenting cardiac muscle cell function are proposed. By shedding light on the intricate molecular mechanisms underlying nuclear-cytoskeletal interactions, the review lays the groundwork for future research and therapeutic interventions aimed at addressing genetic muscle disorders.

Keywords: LINC complex; Molecular mechanisms; Muscular diseases; Nesprin; Nuclear-cytoskeletal interactions; Therapeutic interventions.

Publication types

  • Review

MeSH terms

  • Cytoskeleton / metabolism
  • Humans
  • Muscular Diseases* / metabolism
  • Muscular Dystrophy, Emery-Dreifuss* / genetics
  • Muscular Dystrophy, Emery-Dreifuss* / metabolism
  • Muscular Dystrophy, Emery-Dreifuss* / pathology
  • Nerve Tissue Proteins / metabolism
  • Nuclear Envelope / metabolism
  • Nuclear Envelope / pathology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism

Substances

  • Nuclear Proteins
  • Nerve Tissue Proteins